WESTFORD, Mass., May 7, 2013 /PRNewswire/ -- Cynosure, Inc.
(NASDAQ: CYNO), a leader in laser- and light-based treatments for
minimally invasive and non-invasive aesthetic applications, today
announced that its senior management will present at the UBS Global
Healthcare Conference at 10:30 a.m.
(ET) on Tuesday, May 21 in
New York City.
The presentation by Cynosure President and CEO Michael Davin and Executive Vice President,
Treasurer and CFO Timothy Baker will
be available via live and archived audio webcast accessible through
a link on the Investor Relations section of the Company's website,
www.cynosure.com.
About Cynosure, Inc.
Cynosure develops and markets
aesthetic treatment systems that are used by physicians and other
practitioners to perform non-invasive and minimally invasive
procedures to remove hair, treat vascular and pigmented lesions,
remove multi-colored tattoos, rejuvenate the skin, liquefy and
remove unwanted fat through laser lipolysis, reduce cellulite and
treat onychomycosis. Cynosure's products include a broad range of
laser and other light-based energy sources, including Alexandrite,
pulse dye, Q-switched, Nd:YAG and diode lasers, as well as intense
pulsed light. Cynosure was founded in 1991. For corporate or
product information, visit Cynosure's website at
www.cynosure.com.
Contact:
Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
617.542.5300
cyno@investorrelations.com
SOURCE Cynosure, Inc.